Names and pronunciation
(mel-oks′i-kam) Anjeso, Mobic, Mobicox , Qmiiz ODT, Vivlodex
Source page 836
Individual generic drug information
Extracted information for meloxicam only.
(mel-oks′i-kam) Anjeso, Mobic, Mobicox , Qmiiz ODT, Vivlodex
Source page 836
Func. class.: Antirheumatic, NSAIDs
Source page 836
USES: IV: Pain: Moderate to severe pain in adults, alone or in combination with nonsteroidal antiinflammatory drug analgesics: PO Osteoarthritis, RA (ODT tablet and suspension only)
Source page 836
Extracted information for meloxicam only.
CONTRAINDICATIONS Hypersensitivity to meloxicam or any com- ponent; history of asthma, urticaria, other allergic-type reactions after taking aspirin or other nonsteroidal antiinflammatory drugs; CABG; phenylketonuria (orally disintegrat- ing tablet only); moderate to severe renal disease who are at risk for renal failure due to volume depletion (injection only)
Source page 836
Black Box Warning: CABG, GI bleeding/ perforation, thromboembolism
Source page 836
Extracted information for meloxicam only.
DOSAGE AND ROUTES Capsules and ODT are not interchange- able Osteoarthritis Adult: Capsule: PO Initial: 5 mg daily; may increase to max 10 mg daily Osteoarthritis, rheumatoid arthritis Adult: ODT/tablet/suspension: PO Ini- tial: 7.5 mg once daily; may increase to max 15 mg daily Pain, moderate to severe Adult: IV: 30 mg once daily. Use for the shortest duration consistent with indi- vidual patient treatment goals; may be used as monotherapy or in combination with nonsteroidal antiinflammatory drug analgesics Juvenile idiopathic arthritis (JIA) Child ≥2 yr/adolescent: Oral suspension, tablets: 0.125 mg/kg daily; max 7.5 mg/ day; ODT: Child/adolescent ≥60 kg: 7.5 mg daily
Source pages 836, 837
Available forms: Tabs 7.5, 15 mg; sus- pension 7.5 mg/5 mL; solution for injec- tion 30 mg/mL; ODT tablets 7.5, 15 mg; capsules 5, 10 mg HIGH ALERT
Source page 837
Filter the extracted dose blocks for this individual drug.